SUMMARY Magnetic resonance (MR) imaging and computed tomography (CT) are useful for the evaluation of central nervous system (CNS) lupus. This report describes the use of cranial MR and CT in 21 patients with systemic lupus erythematosus (SLE) with acute neuropsychiatric symptoms manifested by headache, seizures, focal neurological deficits, psychosis, or organic brain syndrome. Computed tomography was found to be insensitive and detected only diffuse atrophy (two cases), cerebral infarct (one case), and intracerebral haemorrhage (one case) in the 21 patients. Cranial MR images obtained with a General Electric 1-5 tesla Signa unit detected labile and fixed areas of increased proton intensity interpreted as focal oedema (eight cases), infarct (10 cases), haemorrhage (one), atrophy (seven), and acute sinusitis (two). Focal oedema was characterised by labile, high intensity lesions in the gray or white matter of the cerebellum, cerebrum, or brain stem, which completely resolved after aggressive corticosteroid treatment. Most high intensity reversible or fixed lesions evident on MR were not apparent on cranial CT images. In several patients sequential MR images were valuable in monitoring the efforts of treatment. Although histological confirmation of the high intensity brain lesions apparent on MR is desirable, prior necropsy studies suggest that pathological confirmation may be difficult owing to the paucity of recognisable brain lesions in patients with CNS lupus. It is concluded that for the evaluation of acute neuropsychiatric SLE MR is useful and provides more information than cranial CT.
intracranial haemorrhage may be confused with active CNS lupus.1
The difficulty in distinguishing clinically between disorders directly attributable to SLE and unrelated neurological processes is due to the non-specific clinical signs that accompany this disease and to the absence of reliable diagnostic methods.1 Computed tomography (CT) and conventional radionuclide scanning are often used but are insensitive to diffuse lupus encephalopathy, the most common form of acute CNS lupus, even in the presence of seizures and acute organic brain syndrome.2 4Because CT is often employed before magnetic resonance (MR) in many medical centres this study compared the sensitivity of MR and CT in the evaluation of 21 patients with SLE with acute neuropsychiatric complaints. 1014
Magnetic resonance and CT imaging in CNS lupus 1015 Patients and methods PATIENT POPULATION Patients with SLE with acute neuropsychiatric complaints were evaluated by the division of clinical immunology and rheumatic diseases at the University of New Mexico School of Medicine. The diagnosis of SLE was established using the 1982 revised American Rheumatism Association criteria.5 Table   1 lists the clinical features of the patients with SLE. Diffuse lupus encephalopathy was defined as the presence of seizures, acute organic brain syndrome, psychosis, or affective disorder, including depression that could not be ascribed to infection, drug effect, infarct, or other CNS lesion. Encephalopathy in this context is not a pathological term, but a clinical description of brain dysfunction. Other CNS disorders (infarct, haemorrhage, atrophy) were defined by characteristic MR or CT findings. Magnetic resonance studies were performed on a 1.5 tesla General Electric Signa system with the 2 5 GE software. Three spin echo scans were performed on each patient: a TR=600 ms/TE=20 ms sagittal, a TR=200 ms/TE=20/80 ms axial, and a TR=2000 msITE=20/80 ms coronal. Slice thickness was 5 mm with a 2 5 mm slice gap and a 256x 128 acquisition matrix. The sagittal field of view was 24 cm with the axial and coronal images performed in a 20 cm field of view. Conventional cranial CT scans with contrast were performed on a GE 9800 scanner and 10 mm slices were taken. Two radiologists trained in MR and CT evaluated all images and reached a consensus about the final interpretation. Tables 3 and 4 summarise the MR findings.
Results

MR FINDINGS IN DIFFUSE LUPUS ENCEPHALOPATHY
The MR findings associated with diffuse encephalopathy included reversible high intensity (increased signal) lesions consistent with focal ischaemia or oedema, and fixed high intensity areas compatible with infarct evident on T2 weighted images ( Table  4) . Eight of 21 patients (38%) had evidence of reversible focal lesions, and all of these patients suffered from diffuse lupus encephalopathy, though some had also shown other transient focal or generalised neurological findings. The most extensive of the reversible lesions were present in those patients with seizures, acute psychosis, severe organic brain syndrome, or focal neurological deficits, though some patients with headache also showed these lesions ( Table 3 ). The anatomical position of these reversible, high intensity lesions was labile, and lesions resolved rapidly with corticosteroid treatment as shown by sequential images (Figs 1 and 2) . None of the high intensity, reversible abnormalities was apparent by conventional CT scanning. shows a rightparietal area ofhigh intensity corresponding to the area offocal atrophy in Fig. 4a (arrowheads) . These lesions did not change with sequential imaging and are consistent with an old area ofinfarction not related to the current episode of acute lupus cerebritis.
TE=20 ms) image which shows an area of focal atrophy. Figure 4b (patient 2) is a 12 weighted image of the same area, which shows a fixed right parietal high intensity lesion representing infarct. Similar high intensity irreversible lesions were observed in the cerebellum.
Cerebral infarction in acute neuropsychiatric SLE was common but usually involved only small areas of the brain and did not usually result in a clinically recognisable focal neurological deficit. On the other hand, an accumulation of such lesions might be expected to result in a gradual decline of intellectual and motor function as the duration of the disease increases.
MR FINDINGS OF DIFFUSE ATROPHY
Cerebral atrophy was a common MR finding in patients with SLE ( Figs 3 and 4) The high intensity lesions evident on MR images may correspond to the sulcal enlargement present on certain CT images described by GonzalezScarano et al,2 but MR is more sensitive and shows discrete lesions rather than the vague, gross structural enlargement present on CT images. These results indicate that labile high intensity brain lesions evident on MR are associated with reversible neurological abnormalities in many patients with SLE and may be a reflection of a diffuse CNS process.
The presence of reversible, oedematous lesions is consistent with the well reported paucity of histopathological lesions associated with CNS lUpUS.7 8 Indeed, the absence of significant disease in most necropsy studies suggests that the reversible high intensity lesions do not represent infarct or necrosis. Reversible oedema of brain could be induced by acute changes in the blood brain barrier secondary to vasculopathy, which would reverse when the barrier defect improved with or without treatment. Likewise, patchy ischaemia could also result in such regional and diffuse abnormalities.9 10 Antineuronal antibodies have been associated with active lupus encephalopathy.11-13 The presence of such antibodies would be consistent with the absence of extensive infarction, the diffuse nature of the process, and the presence of reversible oedema of neural tissue.14 Although histological confirmation of the labile and fixed, high intensity brain lesions apparent on MR is desirable, prior necropsy studies in patients with SLE suggest that pathological confirmation may be difficult or impossible because of the absence of histologically demonstrable lesions in most patients, especially those with diffuse encephalopathy.7 8 The role of corticosteroids in the resolution of labile, high signal intensity lesions is unclear, though our patients received high doses of these drugs. Certainly, further studies would be necessary to determine whether corticosteroids are responsible for the reversibility of high intensity lesions. These studies may be difficult, however, because most clinicians would not withold corticosteroid treatment if the patient were suffering from generalised seizures or psychosis. Indeed, the general trend in treatment of active SLE is towards aggressive corticosteroid and cytotoxic drug treatment. 15 The (10 mm) relative to that of MR (5 mm). Even when slice thickness is considered, however, the large lesions present on MR were not evident on CT, indicating that major differences in sensitivity existed between the two techniques.
In contrast, MR provided useful positive information in 15/21 patients. Thus cranial MR appears preferable for the routine evaluation of acute neuropsychiatric disease in patients with SLE. Six patients in our series, however, suffered from CNS symptoms consistent with mild encephalopathy without overt seizures or psychosis, yet the MR studies were competely normal (Table 4) . Cranial MR, although more sensitive than CT, may be too insensitive to detect lesions in patients with SLE and only mild CNS involvement. Alternatively, mild CNS involvement in SLE may be purely physiological with no changes in anatomical structure or mobile proton content and might therefore be expected to be invisible to both CT and MR.
In conclusion, MR has particular value in the patient with SLE with acute neuropsychiatric complaints. Magnetic resonance detects reversible focal lesions, infarct, atrophy, intracranial haemorrhage, and other CNS lesions that occur commonly in patients with SLE (Table 4 ). In contrast, CT has a low diagnostic yield (less than 10%) in neuropsychiatric SLE. In some patients sequential MR scans may be useful objectively for following the therapeutic response of reversible high proton intensity CNS lesions. We conclude that for the evalua-tion of acute neuropsychiatric SLE MR is useful and provides more information than cranial CT. 
